waiv patent alon won't solv covid-19 vaccin access: develop
geneva (reuter) - waiv intellectu properti right will not be enough to resolv covid-19 vaccin access issu, the develop of the oxford/astrazeneca and the pfizer/biontech vaccin said on mondai, ahead of a meet on the topic at the world trade organ thi week.
